Qatari German Company for Medical Devices (Q.P.S.C.) (QSE:QGMD)

QSE:QGMD Cash Flow Statement

Financials in millions QAR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	9.27	-68.49	1.34	1.24	1.18
Depreciation & Amortization	4.52	4.53	5.35	5.43	5.41
Loss (Gain) From Sale of Assets	-0.06	-	-	-	-
Asset Writedown & Restructuring Costs	2	0.15	-2.11	-	-
Other Operating Activities	-8.6	10.14	1.49	2.32	2.48
Change in Accounts Receivable	2.36	43.65	-17.86	-9.45	-2.48
Change in Inventory	0.39	8.93	2.85	-0.52	-3.36
Change in Accounts Payable	-8.56	2.15	7.96	2.02	5.12
Operating Cash Flow	1.32	1.06	-0.98	1.05	5.76
Operating Cash Flow Growth	24.73%	-	-	-81.83%	-
Capital Expenditures	-0	-0.04	-1.05	-0.25	-0.56
Sale of Property, Plant & Equipment	0.06	-	-	-	-
Other Investing Activities	0.22	-	-	-	-
Investing Cash Flow	0.29	-0.04	-1.05	-0.25	-0.56
Long-Term Debt Issued	-	-	-	0.37	7.89
Total Debt Issued	-	-	-	0.37	7.89
Long-Term Debt Repaid	-1.27	-0.84	-4.2	-0.01	-10.94
Total Debt Repaid	-1.27	-0.84	-4.2	-0.01	-10.94
Net Debt Issued (Repaid)	-1.27	-0.84	-4.2	0.36	-3.05
Financing Cash Flow	-1.27	-0.84	-4.2	0.36	-3.05
Net Cash Flow	0.34	0.18	-6.23	1.15	2.16
Free Cash Flow	1.32	1.02	-2.03	0.8	5.21
Free Cash Flow Growth	29.08%	-	-	-84.72%	-
Free Cash Flow Margin	28.84%	10.23%	-7.28%	1.87%	12.84%
Free Cash Flow Per Share	0.01	0.01	-0.02	0.01	0.04
Cash Interest Paid	0.55	0.57	1.09	1.35	4.74
Levered Free Cash Flow	-6.66	14.99	-4.9	-3.54	1.13
Unlevered Free Cash Flow	-5.61	21.71	-3.21	-1.17	4.09
Change in Working Capital	-5.81	54.72	-7.04	-7.95	-0.72

Source: S&P Global Market Intelligence. Standard template. Financial Sources.